Herantis Pharma Oyj (HRTIS.HE)

EUR 1.66

(0.91%)

Revenue Summary of Herantis Pharma Oyj

Herantis Pharma Oyj's latest annual revenue in 2023 was - EUR , down 0.0% from previous year.
Herantis Pharma Oyj's latest quarterly revenue in 2024 Q2 was - EUR , down 0.0% from previous quarter.
Herantis Pharma Oyj reported a annual revenue of - EUR in annual revenue 2022, down 0.0% from previous year.
Herantis Pharma Oyj reported a annual revenue of - EUR in annual revenue 2021, down 0.0% from previous year.
Herantis Pharma Oyj reported a quarterly revenue of - EUR for 2024 Q2, down 0.0% from previous quarter.
Herantis Pharma Oyj reported a quarterly revenue of - EUR for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Herantis Pharma Oyj (2023 - 2011)

Historical Annual Revenue of Herantis Pharma Oyj (2023 - 2011)

Year	Revenue	Revenue Growth
2023	- EUR	0.0%
2022	- EUR	0.0%
2021	- EUR	0.0%
2020	- EUR	0.0%
2019	- EUR	0.0%
2018	- EUR	0.0%
2017	- EUR	-100.0%
2016	25.29 Thousand EUR	1193.66%
2015	1955.00 EUR	144.38%
2014	800.00 EUR	0.0%
2013	- EUR	-100.0%
2012	43.91 EUR	0.0%
2011	- EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	- EUR	0.0%
2024 Q2	- EUR	0.0%
2023 FY	- EUR	0.0%
2023 Q3	- EUR	0.0%
2023 Q4	- EUR	0.0%
2023 Q2	- EUR	0.0%
2023 Q1	- EUR	0.0%
2022 Q2	- EUR	0.0%
2022 Q1	- EUR	0.0%
2022 FY	- EUR	0.0%
2022 Q4	- EUR	0.0%
2022 Q3	- EUR	0.0%
2021 Q4	- EUR	0.0%
2021 Q1	- EUR	0.0%
2021 FY	- EUR	0.0%
2021 Q3	- EUR	0.0%
2021 Q2	- EUR	0.0%
2020 Q2	- EUR	0.0%
2020 Q4	- EUR	0.0%
2020 FY	- EUR	0.0%
2020 Q1	- EUR	0.0%
2020 Q3	- EUR	0.0%
2019 Q2	- EUR	0.0%
2019 Q3	- EUR	0.0%
2019 FY	- EUR	0.0%
2019 Q1	- EUR	0.0%
2019 Q4	- EUR	0.0%
2018 Q3	- EUR	0.0%
2018 Q4	- EUR	0.0%
2018 FY	- EUR	0.0%
2018 Q2	- EUR	0.0%
2018 Q1	- EUR	0.0%
2017 FY	- EUR	-100.0%
2017 Q4	- EUR	0.0%
2017 Q3	- EUR	0.0%
2017 Q2	- EUR	0.0%
2017 Q1	- EUR	0.0%
2016 Q2	12.64 Thousand EUR	-0.01%
2016 FY	25.29 Thousand EUR	1193.66%
2016 Q4	- EUR	0.0%
2016 Q3	- EUR	-100.0%
2016 Q1	12.64 Thousand EUR	1480.75%
2015 Q3	400.00 EUR	-30.68%
2015 FY	1955.00 EUR	144.38%
2015 Q1	578.00 EUR	44.5%
2015 Q2	577.00 EUR	-0.17%
2015 Q4	800.00 EUR	100.0%
2014 Q1	- EUR	0.0%
2014 Q3	400.00 EUR	0.0%
2014 Q2	- EUR	0.0%
2014 Q4	400.00 EUR	0.0%
2014 FY	800.00 EUR	0.0%
2013 FY	- EUR	-100.0%
2013 Q4	- EUR	0.0%
2013 Q1	- EUR	0.0%
2013 Q3	- EUR	0.0%
2013 Q2	- EUR	0.0%
2012 FY	43.91 EUR	0.0%
2011 FY	- EUR	0.0%

Peer Revenue Comparison of Herantis Pharma Oyj

Name	Revenue	Revenue Difference
Biohit Oyj	13.07 Million EUR	100.0%
Nanoform Finland Oyj	2.56 Million EUR	100.0%